11
Total investments
2
Early stage
4
Mid stage
2
Late stage
9y
Years active
Portfolio
9 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Feb 2023
Partillion Bioscience is an early stage life science company aiming to democratize advanced single-cell assays with its award-winning nanovial platform. Our novel platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological function such as secreted proteins. The validated technology underpinning Partillion’s products has been featured in notable journals such as Science Advances, Advanced Functional Materials, and Lab on Chip and received industry accolades, winning the 2020 SLAS Innovation Award.
Investor
Apr 2022
Codetta Bio™ is developing advanced multi-omic biomarker measurement tools supporting data-driven approaches to understanding the unique genetic, environmental, lifestyle, and clinical factors that contribute to individual health and wellness.
Board Observer
Mar 2022
Cellsonics has re-engineered single cell sample preparation to capture the full potential of each and every tissue specimen. The innovative SimpleFlow tissue dissociation system enables researchers to capture important single cells with a user- and cell-friendly method.
With the SimpleFlow system
- Maintain the native gene expression profile across tissue and cell types.
- Recover the full spectrum of heterogeneous cell populations from solid tissue samples in 4-12 minutes of hands-free processing.
- Dissociate samples in cold temperatures without the use of enzymes preserving sample integrity throughout the process.
- Load solid tissue sample into disposable self-contained SimpleFlow cartridge, load into SimpleFlow instrument, select protocol that minces tissue, dissociates and then filters cells that are recovered in a detachable tube for downstream processes.
Want more information? Visit our website at www.cellsonics.com to learn more and set up a SimpleFlow demo using the website Contact link.
Investor | Late Stage Growth
2022
Menlo Micro is on a mission to create a more energy efficient and sustainable world, with an entirely new category of electronic switches. The Ideal Switch eliminates compromises and tradeoffs by combining the benefits of electromechanical and solid-state switches into the best of both worlds. Menlo is bringing more than 99 percent reductions in size, weight, power, and cost to dozens of industries such as medical, aerospace and defense, telecommunications, consumer electronics, industrial IoT, and test and measurement. For more information, visit menlomicro.com.
Investor
2021
Scribe Biosciences is an early-stage company pioneering technologies to accelerate immunotherapy discoveries through linked functional and genomic profiling of single-cell interactions.
Investor
2020
INSTANT HEALTHCARE AUTOMATION
Shadowbox is a secure, no-code healthcare integration and automation platform.
Investor
2019
Fluent BioSciences, an Illumina company, is a biotechnology company with a mission to accelerate the understanding of biology and disease through simple, cost effective and scalable solutions for every laboratory from research to the clinic.
Fluent’s breakthrough Pre-templated Instant Partitions (PIPseq™) technology enables near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. This powerful platform enables extremely sensitive and unbiased preparation of proteins and nucleic acids for a broad range of discovery and disease applications including single-cell RNA sequencing (scRNA-Seq).
Experience · 16 entries
All (16)
Investments (11)
Founder (2)
Board (3)
2023
Board Observer
Jun 2023
NanoCellect is committed to empowering every scientist to make discoveries one cell at a time, by ensuring high cell viability required to advance cell-based research. We develop and deliver microfluidic based solutions that are affordable, compact, and easy-to-use. Our expanding portfolio of instruments and consumables enable biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, antibody discovery, and basic research.
Board Observer
Feb 2023
Partillion Bioscience is an early stage life science company aiming to democratize advanced single-cell assays with its award-winning nanovial platform. Our novel platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological function such as secreted proteins. The validated technology underpinning Partillion’s products has been featured in notable journals such as Science Advances, Advanced Functional Materials, and Lab on Chip and received industry accolades, winning the 2020 SLAS Innovation Award.
2022
Founder & CEO
Jun 2022
VoiceCare AI is a Healthcare Administration General Intelligence company for the RCM and the back-office.
Our mission is to dramatically improve access, adherence, and outcomes for the patients and the healthcare workforce through the application of generative AI.
Our enterprise-grade AI platform that automates routine phone conversations and tasks for healthcare companies for benefit verification, prior authorization, claims management, prescription support and other such use cases.
Built with security and compliance at its core, we are SOC 2 Type II attested and HIPAA compliant.
Learn more at https://voicecare.ai/
Founder & CEO
May 2022
Stealth AI Startup is an independent initiative focused on founders building AI companies before public launch.
We explore the earliest stages of building an AI startup—from testing an idea and finding collaborators to assembling a team and preparing to launch.
Our focus:
• Founder experiences and lessons from building in stealth
• Emerging AI technologies and startup trends
• Perspectives from founders, researchers, engineers and investors
• Practical learning for the journey from idea to launch
We believe founders can exchange knowledge and build meaningful professional connections while keeping their products and plans confidential.
This is the official LinkedIn Page of the Stealth AI Startup initiative. It represents our initiative, rather than the separate companies built by founders who follow it. Following or engaging with this page does not, by itself, establish employment, partnership or endorsement.
Follow us for perspectives on building AI companies and updates from our initiative.
Visit us at https://www.stealthaistartup.online/
Investor
Apr 2022
Codetta Bio™ is developing advanced multi-omic biomarker measurement tools supporting data-driven approaches to understanding the unique genetic, environmental, lifestyle, and clinical factors that contribute to individual health and wellness.
Show all 16 entries ↓
Investment activity
2017–2023 · 11 investments
Recent (last 2 years)Earlier